Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Powershares S&P 500 High Divide | SPHD | Nov 25, 2024 | 51.34 | +0.39 |
Powershares S&P Midcap Low Vola | XMLV | Nov 25, 2024 | 65.44 | +0.95 |
Powershares S&P Smallcap Low Vo | XSLV | Nov 25, 2024 | 51.34 | +1.26 |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Nov 25, 2024 | 25.10 | +0.08 |
PowerUp Acquisition A | PWUP | Nov 25, 2024 | 11.49 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Nov 25, 2024 | 11.45 | 0.00 |
PPG Industries | PPG | Nov 25, 2024 | 125.79 | +2.56 |
PPL | PPL | Nov 25, 2024 | 34.40 | -0.15 |
PRA Group | PRAA | Nov 25, 2024 | 21.69 | -0.14 |
Prairie Operating | PROP | Nov 25, 2024 | 8.66 | -1.25 |
Praxis Precision Medicines | PRAX | Nov 25, 2024 | 74.68 | +0.24 |
Precigen | PGEN | Nov 25, 2024 | 0.93 | +3.06 |
Precipio | PRPO | Nov 25, 2024 | 5.90 | -0.16 |
Precision BioSciences | DTIL | Nov 25, 2024 | 7.24 | -0.28 |
Precision Drilling | PDS | Nov 25, 2024 | 64.60 | -2.68 |
Precision Optics | POCI | Nov 25, 2024 | 5.08 | -0.59 |
Predictive Oncology | POAI | Nov 25, 2024 | 0.75 | +4.76 |
Preferred Bank | PFBC | Nov 25, 2024 | 96.73 | +1.11 |
Preferred Portfolio Powershares | PGX | Nov 25, 2024 | 12.02 | +0.59 |
Preformed Line Products | PLPC | Nov 25, 2024 | 143.56 | +3.64 |
Prelude Therapeutics | PRLD | Nov 25, 2024 | 0.96 | +1.63 |
Premier A | PINC | Nov 25, 2024 | 23.16 | +1.40 |
Premier Financial | PFC | Nov 25, 2024 | 28.52 | -1.14 |
Premium Catering Holdings | PC | Nov 25, 2024 | 0.82 | 0.00 |
Prenetics Global A | PRE | Nov 25, 2024 | 4.51 | +2.04 |
Presidio Property Trust A | SQFT | Nov 25, 2024 | 0.63 | +11.02 |
Presidio Property Trust D Pref | SQFTP | Nov 25, 2024 | 14.50 | +0.00 |
Prestige Consumer Healthcare | PBH | Nov 25, 2024 | 84.65 | -0.24 |
Prestige Wealth | PWM | Nov 25, 2024 | 1.04 | -2.80 |
PriceSmart | PSMT | Nov 25, 2024 | 90.92 | +1.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.